“…[90][91][92][93][94][95][96] The impact of mutations on function can be monitored by ATPase assays [79,90,[97][98][99][100][101] or transport assays. [78,90,[105][106][107][108]93,94,96,97,100,[102][103][104] In transport assays, the protein is either overexpressed in a cell or incorporated into liposomes and the accumulation of fluorescent [78,97,105] or radiolabeled substrate [90,93,94,96,100,102,103,[106][107][108] in the compartment (cell or vesicle) is measured. Good examples for such careful controls are LmrP transporter variants whose activities were checked with the fluorescent ligand Hoechst, [105] or variants of the Glt Ph transporter in liposomes where the uptake of the radioactive substrate [ 3 H]-Asp was used to confirm activity.…”